EFIB Stakeholder Profile​

Company/Organisation type: Industry

Focus area/active in:

  • Animal Feed & Additives
  • Bio-based Chemistry
  • Bio-based Materials
  • Enzyme Technologies & Bioprocesses
  • Equipment / Automation / Analytics
  • Food / Nutrition / Ingredients
  • Strain Development
  • Synthetic Biology


Inscripta is developing the world’s first benchtop platform for scalable digital genome engineering. The company’s advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at unprecedented scale. Inscripta’s goal is to empower scientists whose gene editing research is stifled by current technical and licensing limitations. The company enables scientists to realize a new era of biological discovery. Inscripta is headquartered in Boulder, Colo., with offices in Pleasanton, Calif., and San Diego. For more information, visit www​.inscrip​ta​.com.


Follow us:

Inscripta Onyx Launch Short Video

Visit to learn more

Get in touch!

Kim Soerensen
Vice President & GM EMEA

Please fill out the form below to get in touch with us.